Showing results (621-630 of 688) with videos related to

Sort By:
Pageof 69
Lancet (London, England)|June 21, 2017
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trialRoy Fleischmann, Eduardo Mysler, Stephen Hall, et al.
Annals of the Rheumatic Diseases|August 8, 2013
The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a Mendelian randomisation studyKalliope Panoutsopoulou, Sarah Metrustry, Sally A Doherty, et al.
Annals of the Rheumatic Diseases|November 13, 2012
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statementMonika M Schoels, Désirée van der Heijde, Ferdinand C Breedveld, et al.
The Journal of Rheumatology|October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Clinical and Experimental Rheumatology|June 26, 2010
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosisDoerte Huscher, David Pittrow, Oliver Distler, et al.
Micromachines|May 27, 2023
Proof-of-Concept Vacuum Microelectronic NOR Gate Fabricated Using Microelectromechanical Systems and Carbon Nanotube Field EmittersTasso von Windheim, Kristin H Gilchrist, Charles B Parker, et al.
Arthritis Research & Therapy|June 14, 2012
N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control studyVivek Thakkar, Wendy M Stevens, David Prior, et al.
Arthritis and Rheumatism|August 1, 2009
Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritisPaul Emery, Roy M Fleischmann, Larry W Moreland, et al.
The Journal of Rheumatology|December 4, 2009
Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS groupOtylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Rheumatology and Therapy|June 8, 2020
Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension StudyPeter Nash, Laura C Coates, Alan J Kivitz, et al.
Pageof 69